{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:25:56Z","timestamp":1778779556487,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1007\/s11920-002-0069-7","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T21:16:25Z","timestamp":1180732585000},"page":"419-428","source":"Crossref","is-referenced-by-count":59,"title":["The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders"],"prefix":"10.1007","volume":"4","author":[{"given":"Andrea J.","family":"Rapkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Mikacich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Moatakef-Imani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Rasgon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"69_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1977.01770130100011","volume":"34","author":"MM Weissman","year":"1977","unstructured":"Weissman MM, Klerman GL: Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977, 34:98\u2013111.","journal-title":"Arch Gen Psychiatry"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.v63n0403","volume":"63","author":"MP Freeman","year":"2002","unstructured":"Freeman MP, Smith KW, Freeman SA, et al.: The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002, 63:284\u2013287.","journal-title":"J Clin Psychiatry"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0033-3182(85)72792-2","volume":"26","author":"WM Harrison","year":"1985","unstructured":"Harrison WM, Rabkin JG, Endicott J: Psychiatric evaluation of premenstrual changes. Psychosomatics 1985, 26:789\u2013799.","journal-title":"Psychosomatics"},{"key":"69_CR4","first-page":"1","volume-title":"ACOG Practice Bulletin: Premenstrual Syndromes","author":"American College of Obstetricians and Gynecologists","year":"2000","unstructured":"American College of Obstetricians and Gynecologists: ACOG Practice Bulletin: Premenstrual Syndromes. Washington, DC; American College of Obstetricians and Gynecologists: 2000:1\u20139."},{"key":"69_CR5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00006842-199509000-00007","volume":"57","author":"EW Freeman","year":"1995","unstructured":"Freeman EW, Schweizer E, Rickels K: Personality factors in women with premenstrual syndrome. Psychosom Med 1995, 57:453\u2013459.","journal-title":"Psychosom Med"},{"key":"69_CR6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/152460901753285778","volume":"10","author":"CN Soares","year":"2001","unstructured":"Soares CN, Cohen LS, Otto MW, Harlow BL: Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J Womens Health Gend Based Med 2001, 10:873\u2013878.","journal-title":"J Womens Health Gend Based Med"},{"key":"69_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jcem-68-1-125","volume":"68","author":"S Hammarback","year":"1989","unstructured":"Hammarback S, Damber JE, Backstrom CT: Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 1989, 68:125\u2013130.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-0327(90)90126-S","volume":"20","author":"TB Pearlstein","year":"1990","unstructured":"Pearlstein TB, Frank E, Rivera-Tovar A, et al.: Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990, 20:129\u2013134.","journal-title":"J Affect Disord"},{"key":"69_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s007370050041","volume":"2","author":"AJ Rapkin","year":"1999","unstructured":"Rapkin AJ: Progesterone, GABA and mood disorders in women. Arch Womens Ment Health 1999, 2:97\u2013105.","journal-title":"Arch Womens Ment Health"},{"key":"69_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0962279901000345","volume":"9","author":"AJ Rapkin","year":"2001","unstructured":"Rapkin AJ, Mikacich JA: Premenstrual syndrome: gynecology or psychiatry? Reprod Med Rev 2001, 9:223\u2013239.","journal-title":"Reprod Med Rev"},{"key":"69_CR11","first-page":"227","volume":"54","author":"M Holzbauer","year":"1976","unstructured":"Holzbauer M: Physiological aspects of steroids with anaesthetic properties. Med Biol 1976, 54:227\u2013242.","journal-title":"Med Biol"},{"key":"69_CR12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/31948","volume":"392","author":"SS Smith","year":"1998","unstructured":"Smith SS, Gong QH, Hsu FC, Markowitz RS, et al.: GABAA receptor alpha-4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998, 392:926\u2013929.","journal-title":"Nature"},{"key":"69_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","volume":"90","author":"AJ Rapkin","year":"1997","unstructured":"Rapkin AJ, Morgan M, Goldman L, et al.: Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997, 90:709\u2013714.","journal-title":"Obstet Gynecol"},{"key":"69_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1420269","volume":"142","author":"P Monteleone","year":"2000","unstructured":"Monteleone P, Luisi S, Tonetti A, et al.: Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 2000, 142:269\u2013273.","journal-title":"Eur J Endocrinol"},{"key":"69_CR15","first-page":"1076","volume":"81","author":"M Wang","year":"1996","unstructured":"Wang M, Seippel L, Purdy RH, Backstrom T: Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3, 20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 1996, 81:1076\u20131082.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR16","first-page":"1256","volume":"79","author":"PJ Schmidt","year":"1994","unstructured":"Schmidt PJ, Purdy RH, Moore PH, et al.: Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 1994, 79:1256\u20131260.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0006-3223(00)01044-1","volume":"49","author":"SS Girdler","year":"2001","unstructured":"Girdler SS, Straneva PA, Light KC, et al.: Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 2001, 49:788\u2013797.","journal-title":"Biol Psychiatry"},{"key":"69_CR18","first-page":"16","volume":"12","author":"I Sundstrom","year":"1998","unstructured":"Sundstrom I, Andersson A, Nyberg S, et al.: Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998, 12:16\u201318.","journal-title":"Neuroendocrinology"},{"key":"69_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.93.22.12599","volume":"93","author":"DP Uzunov","year":"1996","unstructured":"Uzunov DP, Cooper TB, Costa E, Guidotti A: Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A 1996, 93:599\u2013604.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"69_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-199708000-00004","volume":"17","author":"TB Pearlstein","year":"1997","unstructured":"Pearlstein TB, Stone AB, Lund SA, et al.: Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 1997, 17:261\u2013266.","journal-title":"J Clin Psychopharmacol"},{"key":"69_CR21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM199506083322301","volume":"332","author":"M Steiner","year":"1995","unstructured":"Steiner M, Steinberg S, Stewart D, et al.: Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995, 332:1529\u20131534.","journal-title":"N Engl J Med"},{"key":"69_CR22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1997.03550120043031","volume":"278","author":"KA Yonkers","year":"1997","unstructured":"Yonkers KA, Halbreich U, Freeman E, et al.: Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: a randomized controlled trial. JAMA 1997, 278:983\u2013988.","journal-title":"JAMA"},{"key":"69_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4088\/JCP.v58n0905","volume":"58","author":"U Halbreich","year":"1997","unstructured":"Halbreich U, Smoller JW: Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997, 58:399\u2013402.","journal-title":"J Clin Psychiatry"},{"key":"69_CR24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199810000-00007","volume":"18","author":"L Wikander","year":"1998","unstructured":"Wikander L, Sundblad C, Andersch B, et al.: Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998, 18:390\u2013398.","journal-title":"J Clin Psychopharmacol"},{"key":"69_CR25","first-page":"737","volume":"98","author":"EW Freeman","year":"2001","unstructured":"Freeman EW, Rickels K, Yonkers KA, et al.: Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 2001, 98:737\u2013744. Venlafaxine is shown in this randomized, controlled trial to be significantly more efficacious than placebo in the treatment of PMDD, reinforcing the use of SSRIs in premenstrual mood disorders.","journal-title":"Obstet Gynecol"},{"key":"69_CR26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM198411223112104","volume":"311","author":"KN Muse","year":"1984","unstructured":"Muse KN, Cetel NS, Futterman LA, Yen SSC: The premenstrual syndrome: effects of \"medical ovariectomy.\" N Engl J Med 1984, 311:1345\u20131349.","journal-title":"N Engl J Med"},{"key":"69_CR27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1210\/jcem-72-2-252","volume":"71","author":"JF Mortola","year":"1991","unstructured":"Mortola JF, Girton L, Fischer U: Successful treatment of severe premenstrual syndrome by combined use of gonadotropinreleasing hormone agonist and estrogen\/progestin. J Clin Endocrinol Metab 1991, 71:252\u2013252.","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(16)57053-8","volume":"62","author":"G Mezrow","year":"1994","unstructured":"Mezrow G, Shoupe D, Spicer D, et al.: Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril 1994, 62:932\u2013937.","journal-title":"Fertil Steril"},{"key":"69_CR29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0015-0282(16)54718-9","volume":"56","author":"U Halbreich","year":"1991","unstructured":"Halbreich U, Rojansky N, Palter S: Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 1991, 56:1066\u20131069.","journal-title":"Fertil Steril"},{"key":"69_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","volume":"20","author":"EW Freeman","year":"2001","unstructured":"Freeman EW, Kroll R, Rapkin A, et al.: Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001, 20:561\u2013596. The authors present data supporting the use of a novel oral contraceptive containing the progestin drospirenone, a spironolactone derivative, in the treatment of PMDD.","journal-title":"J Womens Health Gend Based Med"},{"key":"69_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-1781(99)00043-8","volume":"86","author":"RW Lam","year":"1999","unstructured":"Lam RW, Carter D, Misri S, et al.: A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res 1999, 86:185\u2013192.","journal-title":"Psychiatry Res"},{"key":"69_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00005-5","volume":"45","author":"S Steinberg","year":"1999","unstructured":"Steinberg S, Annable L, Young SN, Liyanage N: A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry 1999, 45:313\u2013320.","journal-title":"Biol Psychiatry"},{"key":"69_CR33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","volume":"179","author":"S Thys-Jacobs","year":"1998","unstructured":"Thys-Jacobs S, Starkey P, Bernstein D, Tian J: Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998, 179:444\u2013452.","journal-title":"Am J Obstet Gynecol"},{"key":"69_CR34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1026667720478","volume":"4","author":"D Civic","year":"2000","unstructured":"Civic D, Holt UL: Maternal depressive symptoms and child behavior problems in nationally representative normal birth weight sample. Matern Child Health J 2000, 4:251\u2013261.","journal-title":"Matern Child Health J"},{"key":"69_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02646839408408872","volume":"12","author":"R Small","year":"1994","unstructured":"Small R, Brown S, Lumley J, Astbury J: Missing voices: what women say and do about depression after childbirth. J Reprod Infant Psychol 1994, 12:19\u201322.","journal-title":"J Reprod Infant Psychol"},{"key":"69_CR36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1471-0528.2000.tb11607.x","volume":"107","author":"S Brown","year":"2000","unstructured":"Brown S, Lumley J: Physical health problems after childbirth and maternal depression at six to seven months postpartum. Br J Obstet Gynaecol 2000, 107:1194\u20132001.","journal-title":"Br J Obstet Gynaecol"},{"key":"69_CR37","first-page":"23","volume":"39","author":"HW Jones","year":"2001","unstructured":"Jones HW, Venis JA: Identification and classification of postpartum psychiatric disorders. J Psychol Nursing 2001, 39:23\u201329.","journal-title":"J Psychol Nursing"},{"key":"69_CR38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/00048678809161211","volume":"22","author":"CC Hapgood","year":"1988","unstructured":"Hapgood CC, Elkind GS, Wright JJ: Maternity blues: phenomena and relationship to later postpartum depression. Aust N Z J Psychiatry 1988, 22:299\u2013306.","journal-title":"Aust N Z J Psychiatry"},{"key":"69_CR39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bmj.308.6934.949","volume":"308","author":"B Harris","year":"1994","unstructured":"Harris B, Lovett L, Newcombe RG, et al.: Maternity blues and major endocrine changes. BMJ 1994, 308:949\u2013953.","journal-title":"BMJ"},{"key":"69_CR40","first-page":"77","volume":"97","author":"R Nappi","year":"2001","unstructured":"Nappi R, Petraglia F, Luisi S, et al.: Serum allopregnanolone in women with postpartum blues. Obstet Gynecol 2001, 97:77\u201380. The authors showed that serum levels of allopregnanolone were significantly decreased in postpartum women with \"maternity blues,\" confirming the importance of neuroactive metabolites in the psychologic adjustments to pregnancy and motherhood.","journal-title":"Obstet Gynecol"},{"key":"69_CR41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1600-0412.2001.080003251.x","volume":"80","author":"A Jossefson","year":"2001","unstructured":"Jossefson A, Berg G, Nardin C, et al.: Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand 2001, 80:251\u2013255.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"69_CR42","volume-title":"Diagnostic and Statistical Manual of Mental Disorder","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorder, edn 4. Washington, DC: American Psychiatric Press; 1994.","edition":"edn 4"},{"key":"69_CR43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1192\/bjp.154.5.660","volume":"154","author":"B Harris","year":"1989","unstructured":"Harris B, Huckle P, Thomas R, et al.: The hormonal environment of postnatal depression. Br J Psychiatry 1989, 154:660\u2013667.","journal-title":"Br J Psychiatry"},{"key":"69_CR44","first-page":"97","volume":"45","author":"R Dankner","year":"2000","unstructured":"Dankner R, Goldberg RP, Fisch RZ, Crum RM: Cultural elements of postpartum depression: a study of 327 Jewish Jerusalem women. J Reprod Med 2000, 45:97\u2013104.","journal-title":"J Reprod Med"},{"key":"69_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1037\/0021-843X.100.1.63","volume":"100","author":"MW O\u2019Hara","year":"1991","unstructured":"O\u2019Hara MW, Schlecte JA, Lewis DA, et al.: Controlled prospective study of postpartum mood disorders. J Abnorm Psychol 1991, 100:63\u201373.","journal-title":"J Abnorm Psychol"},{"key":"69_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-0327(98)00185-2","volume":"54","author":"KD Jennings","year":"1999","unstructured":"Jennings KD, Ross S, Popper S, et al.: Thought of harming infants in depressed and not depressed mothers. J Affect Disord 1999, 54:21\u201328.","journal-title":"J Affect Disord"},{"key":"69_CR47","first-page":"49","volume":"18","author":"LJ Miller","year":"1998","unstructured":"Miller LJ: Pharmacotherapy during the perinatal period. Dir Psychiatry 1998, 18:49\u201363.","journal-title":"Dir Psychiatry"},{"key":"69_CR48","first-page":"1","volume":"110","author":"LL Altshuler","year":"2001","unstructured":"Altshuler LL, Cohen SL, Moline ML, et al.: The expert consensus guideline series: treatment of depression in women 2001. Postgrad Med 2001, 110:1\u2013116. This special report consists of the composite recommendations of a panel of women\u2019s health experts in the treatment of depression during various reproductive life stages.","journal-title":"Postgrad Med"},{"key":"69_CR49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1192\/S0007125000160593","volume":"180","author":"V Hendrick","year":"2002","unstructured":"Hendrick V, Fukuchi A, Altshuler L, et al.: Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2002, 180:85\u201386.","journal-title":"Br J Psychiatry"},{"key":"69_CR50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1542\/peds.89.4.676","volume":"89","author":"KG Burch","year":"1992","unstructured":"Burch KG, Wells BG: Fluoxetine\/norfluoxetine concentration in mother\u2019s milk. Pediatrics 1992, 89:676\u2013677.","journal-title":"Pediatrics"},{"key":"69_CR51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4088\/JCP.v62n0504","volume":"62","author":"A Ahokas","year":"2001","unstructured":"Ahokas A, Kaukoranata J, Wahlbeck K, Aito M: Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17-beta-estradiol. A Preliminary Study. J Clin Psychiatry 2001, 62:332\u2013336.","journal-title":"J Clin Psychiatry"},{"key":"69_CR52","first-page":"124","volume":"10","author":"CM Klier","year":"2000","unstructured":"Klier CM, Muzik M, Rosenblum KL, Lenz G: Interpersonal psychotherapy adapted for the group setting in the treatment of postpartum depression. J Psycother Pract Res 2000, 10:124\u2013131.","journal-title":"J Psycother Pract Res"},{"key":"69_CR53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/070674370004500607","volume":"45","author":"S Misri","year":"2000","unstructured":"Misri S, Kostaras X, Fox D, et al.: The impact of partner support in the treatment of postpartum psychosis. Can J Psychiatry 2000, 45:554\u2013558.","journal-title":"Can J Psychiatry"},{"key":"69_CR54","first-page":"3000","volume":"30","author":"JO Berle","year":"1999","unstructured":"Berle JO: Severe postpartum depression and psychosis: when is electroconvulsive therapy the treatment of choice? Tidsskr Nor Laegeforen 1999, 30:3000\u20133003.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"69_CR55","first-page":"99","volume-title":"Postpartum Mood Disorder","author":"E Attia","year":"1999","unstructured":"Attia E, Downey J, Oberman M: Postpartum psychosis. In In Postpartum Mood Disorder, Edited by Miller LJ. Washington DC: American Psychiatric Press; 1999:99\u2013117."},{"key":"69_CR56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1192\/bjp.150.5.662","volume":"150","author":"RE Kendel","year":"1987","unstructured":"Kendel RE, Chalmers JC, Platz C: Epidemiology of puerperal psychoses. Br J Psychiatry 1987, 150:662\u2013673.","journal-title":"Br J Psychiatry"},{"key":"69_CR57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000284823","volume":"26","author":"A Rohde","year":"1993","unstructured":"Rohde A, Marneros A: Postpartum psychosis: onset and long term course. Psycho Path 1993, 26:203\u2013209.","journal-title":"Psycho Path"},{"key":"69_CR58","first-page":"1059","volume-title":"Comprehensive Textbook of Psychiatry","author":"BL Parry","year":"1990","unstructured":"Parry BL: Postpartum psychiatric syndrome. In In Comprehensive Textbook of Psychiatry, vol 1. Edited by Kaplan H, Sandock B. Philadelphia: Williams & Wilkins; 1990:1059\u20131066."},{"key":"69_CR59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4088\/JCP.v61n0303","volume":"61","author":"A Aokas","year":"2000","unstructured":"Aokas A, Aito M, Rimon R: Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry 2000, 61:166\u2013169.","journal-title":"J Clin Psychiatry"},{"key":"69_CR60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0033-3182(98)71355-6","volume":"39","author":"V Hendrick","year":"1998","unstructured":"Hendrick V, Altshuler L, Suri R: Hormonal change in postpartum and amplification for postpartum depression. Psychosomatics 1998, 39:93\u2013101.","journal-title":"Psychosomatics"},{"key":"69_CR61","first-page":"63","volume-title":"Women\u2019s Mental Health","author":"VK Burt","year":"1997","unstructured":"Burt VK, Hendrick VC: Women\u2019s Mental Health. Washington, DC: American Psychiatric Press; 1997:63\u201377."},{"key":"69_CR62","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.158.3.393","volume":"158","author":"DE Stewart","year":"1991","unstructured":"Stewart DE, Klompen Havwer JL, Kendell RE, Van Hulst AM: Prophylactic lithium in puerperal psychosis: the experience of three centers. Br J Psychiatry 1991, 158:393\u2013397.","journal-title":"Br J Psychiatry"},{"key":"69_CR63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0887-6185(88)90004-7","volume":"2","author":"KH Bourdon","year":"1998","unstructured":"Bourdon KH, Boyd JH, Rae DS, et al.: Gender differences in phobias: results of the ECA community survey. J Anxiety Disord 1998, 2:227\u2013241.","journal-title":"J Anxiety Disord"},{"key":"69_CR64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0889-8545(05)70199-6","volume":"28","author":"CS Brown","year":"2001","unstructured":"Brown CS: Depression and anxiety disorder. Obstet Gynecol Clin North Am 2001, 28:241\u2013268.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"69_CR65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4088\/JCP.v58n0709","volume":"58","author":"KE Williams","year":"1997","unstructured":"Williams KE, Koran LM: Obsessive-compulsive disorder in pregnancy, the puerperium and the premenstrual. J Clin Psychiatry 1997, 58:330\u2013334.","journal-title":"J Clin Psychiatry"},{"key":"69_CR66","first-page":"5","volume":"49","author":"DL Chambless","year":"1996","unstructured":"Chambless DL, Sanderson WC: An update on empirically validated therapies. Clin Psychol 1996, 49:5\u201322.","journal-title":"Clin Psychol"},{"key":"69_CR67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0005-7894(05)80367-3","volume":"22","author":"MG Craske","year":"1991","unstructured":"Craske MG, Brown TA, Barlow DH: Behavioral treatment of panic disorder: a two-year follow-up. Behav Ther 1991, 22:289\u2013304.","journal-title":"Behav Ther"},{"key":"69_CR68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1049-3867(01)00140-2","volume":"12","author":"RB Weisberg","year":"2002","unstructured":"Weisberg RB, Paquette JA: Screening and treatment of anxiety disorders in pregnant and lactating women. Womens Health Issues 2002, 12:32\u201336.","journal-title":"Womens Health Issues"},{"key":"69_CR69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archpsyc.56.5.418","volume":"56","author":"BL Harlow","year":"1999","unstructured":"Harlow BL, Cohen LS, Otto MW, et al.: Prevalence and predictors of depressive symptoms in older premenopausal women. Arch Gen Psychiatry 1999, 56:418\u2013424. The results of questionnaires sent to women aged 36 to 44 years corroborate the prevalence of depression reported by other community-based studies. In addition, the results support a relationship between depressive symptoms and various risk factors: marital status, cigarette smoking, nulliparity, and premenstrual symptoms.","journal-title":"Arch Gen Psychiatry"},{"key":"69_CR70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/01674829909075577","volume":"20","author":"C Novaes","year":"1999","unstructured":"Novaes C, Almeida OP: Premenstrual syndrome and psychiatric morbidity at the menopause. J Psychosom Obstet Gynecol 1999, 20:56\u201357.","journal-title":"J Psychosom Obstet Gynecol"},{"key":"69_CR71","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/13697139809085553","volume":"1","author":"C Novaes","year":"1998","unstructured":"Novaes C, Almeida OP, de Melo NR: Mental health among perimenopausal women attending a menopause clinic: possible association with premenstrual syndrome? Climacteric 1998, 1:264\u2013270.","journal-title":"Climacteric"},{"key":"69_CR72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/1047-2797(94)90099-X","volume":"4","author":"NE Avis","year":"1994","unstructured":"Avis NE, Brambilla D, McKinlay SM, Vass K: A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women\u2019s Health Study. Ann Epidemiol 1994, 4:214\u2013220.","journal-title":"Ann Epidemiol"},{"key":"69_CR73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0531-5565(94)90008-6","volume":"29","author":"HL Judd","year":"1994","unstructured":"Judd HL, Fournet N: Changes of ovarian hormonal function with aging. Exp Gerontol 1994, 29:285\u2013298.","journal-title":"Exp Gerontol"},{"key":"69_CR74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-2008-1067971","volume":"15","author":"PJ Schmidt","year":"1997","unstructured":"Schmidt PJ, Roca CA, Bloch M, Rubinow DR: The perimenopause and affective disorders. Semin Reprod Endocrinol 1997, 15:91\u2013100.","journal-title":"Semin Reprod Endocrinol"},{"key":"69_CR75","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0378-5122(02)00011-7","volume":"41","author":"M Banger","year":"2002","unstructured":"Banger M: Affective syndrome during perimenopause. Maturitas 2002, 41(suppl):S13-S18.","journal-title":"Maturitas"},{"key":"69_CR76","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0006-3223(98)00169-3","volume":"44","author":"H Joffe","year":"1998","unstructured":"Joffe H, Cohen LS: Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry 1998, 44:798\u2013811.","journal-title":"Biol Psychiatry"},{"key":"69_CR77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0165-0327(99)00189-5","volume":"63","author":"MC Becht","year":"2001","unstructured":"Becht MC, Van Erp CF, Teeuwisse TM, et al.: Measuring depression in women around menopausal age: toward a validation of the Edinburgh Depression Scale. J Affect Disord 2001, 63:209\u2013213.","journal-title":"J Affect Disord"},{"key":"69_CR78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004040000108","volume":"264","author":"N Sagsoz","year":"2001","unstructured":"Sagsoz N, Oguzturk O, Bayram M, Kamaci M: Anxiety and depression before and after the menopause. Arch Gynecol Obstet 2001, 264:199\u2013202.","journal-title":"Arch Gynecol Obstet"},{"key":"69_CR79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Waard CH, Mendelson M, et al.: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561\u2013571.","journal-title":"Arch Gen Psychiatry"},{"key":"69_CR80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(96)82006-8","volume":"24","author":"JR Hilditch","year":"1996","unstructured":"Hilditch JR, Lewis J: The menopause-specific quality of life questionnaire. Maturitas 1996, 24:161\u2013175.","journal-title":"Maturitas"},{"key":"69_CR81","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.48.5_Suppl_7.8S","volume":"48","author":"BS McEwen","year":"1997","unstructured":"McEwen BS, Alves SE, Bulloch K, Weiland NG: Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997, 48(suppl):S8-S15.","journal-title":"Neurology"},{"key":"69_CR82","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S0893-133X(01)00340-2","volume":"25","author":"BL Parry","year":"2001","unstructured":"Parry BL, Newton RP: Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology 2001, 25:S102-S108.","journal-title":"Neuropsychopharmacology"},{"key":"69_CR83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.58.6.529","volume":"58","author":"CN Soares","year":"2001","unstructured":"Soares CN, Almeida OP, Joffe H, Cohen LS: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001, 58:529\u2013534.","journal-title":"Arch Gen Psychiatry"},{"key":"69_CR84","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mob.2000.106004","volume":"183","author":"PJ Schmidt","year":"2000","unstructured":"Schmidt PJ, Nieman L, Danaceau MA, et al.: Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000, 183:414\u2013420. This report of a randomized, controlled trial of 17-beta-estradiol in depressed perimenopausal women demonstrates the effectiveness of estrogen in treating perimenopausal depression independent of its effectiveness in alleviating vasomotor symptoms.","journal-title":"Am J Obstet Gynecol"},{"key":"69_CR85","first-page":"391","volume":"98","author":"LE Hollander","year":"2001","unstructured":"Hollander LE, Freeman EW, Sammel MD, et al.: Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 2001, 98:391\u2013397.","journal-title":"Obstet Gynecol"},{"key":"69_CR86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.v63n0910","volume":"63","author":"LL Altshuler","year":"2002","unstructured":"Altshuler LL: The use of SSRIs in depressive disorders specific to women. J Clin Psychiatry 2002, 63(suppl):3\u20138.","journal-title":"J Clin Psychiatry"},{"key":"69_CR87","first-page":"45","volume":"63","author":"NL Rasgon","year":"2002","unstructured":"Rasgon NL, Altshuler LL, Fairbanks LA, et al.: Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002, 63(suppl):45\u201348.","journal-title":"J Clin Psychiatry"},{"key":"69_CR88","first-page":"139","volume":"4","author":"RF Casper","year":"1997","unstructured":"Casper RF, Dodin S, Reid RL, et al.: The effect of 20 mg ethinyl estradiol\/1 mg norethindrone acetate, a low-dose oral contraceptive, on vaginal bleeding patterns, hot flashes, and quality of life in symptomatic perimenopausal women. J North Am Menopause Soc 1997, 4:139\u2013147.","journal-title":"J North Am Menopause Soc"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-002-0069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-002-0069-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-002-0069-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:42:11Z","timestamp":1707936131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-002-0069-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s11920-002-0069-7","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}